Evidence map›Paper›PMID 41244973›Full record

ArticleASM case reports2025

Whole genome sequencing confirmed the

Huanyu Wang, Sophonie J Oyeniran, Kathy Everhart, Amy L Leber

Abstract readCase Reports
In one paragraph

Article in ASM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. A Case of Macrolide-Resistant Mycoplasma Pneumonia Developing Shortly After Macrolide-Susceptible Infection.Pediatrics international : official journal of the Japan Pediatric Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huanyu WangDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Sophonie J OyeniranDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0001-9372-3491
Kathy EverhartDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Amy L LeberDepartment of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0002-3075-3586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Case Summary: A previously healthy 11-year-old male was diagnosed with MPN infection and received azithromycin treatment. His symptoms continued after two courses of azithromycin, and he tested positive for MPN DNA three times. Sanger sequencing of samples collected after his first course of azithromycin revealed a mutation conferring macrolide resistance, while the sample collected before the initiation of antibiotics did not. Additionally, whole genome sequencing (WGS) and single-nucleotide polymorphism (SNP) analysis demonstrated that samples collected before and after receiving azithromycin differed by one SNP, indicating that the two isolates are the same strain, and the development of macrolide resistance occurred Conclusion: Our case utilized WGS to confirm that the development of

Indexed as

macrolide resistanceMycoplasma pneumoniaewhole genome sequencing

Identifiers

PMID41244973
PMCPMC12530247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.